Acevedo C. Sylvia M. Schaible E. Graham J.L. Stanhope K.L. Metz L.N. Gludovatz B. Schwartz A.V. Ritchie R.O. Alliston T.N. Havel P.J. Fields A.J.

Contributions of material properties and structure to increased bone fragility for a given bone mass in the UCD-T2DM rat model of type 2 diabetes.

J. Bone Miner. Res. 33: 1066-1075Bajaj D. Geissler J.R. Allen M.R. Burr D.B. Fritton J.C.

The resistance of cortical bone tissue to failure under cyclic loading is reduced with alendronate.

Bone. 83: 57-64Benoit A. Guérard S. Gillet B. Guillot G. Hild F. Mitton D. Périé J.-N. Roux S.

3D analysis from micro-MRI during in situ compression on cancellous bone.

J. Biomech. 42: 2381-2386Bokam P. Germaneau A. Breque C. Rigoard P. Vendeuvre T. Valle V.

Fracture behavior of cancellous bone and cancellous bone-PMMA bone cement interface: an experimental study using an integrated methodology (wedge splitting test and Heaviside-based digital image correlation).

J. Mech. Behav. Biomed. Mater. 122104663Brouwers J. Ruchelsman M. Rietbergen B.V. Bouxsein M.L.

Determination of rat vertebral bone compressive fatigue properties in untreated intact rats and zoledronic-acid-treated, ovariectomized rats.

Osteoporos. Int. 20: 1377-1384Burghardt A.J. Issever A.S. Schwartz A.V. Davis K.A. Masharani U. Majumdar S. Link T.M.

High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus.

J. Clin. Endocrinol. Metab. 95: 5045-5055Carnovale C. Dassano A. Mosini G. Mazhar F. Clementi E.

The β-cell effect of verapamil-based treatment in patients with type 2 diabetes: a systematic review.

Acta Diabetol. 57: 1-15

Type 2 diabetes mellitus and bone.

J. Intern. Med. 283: 140-153Cooper D. Turinsky A. Sensen C. Hallgrimsson B.

Effect of voxel size on 3D micro-CT analysis of cortical bone porosity.

Calcif. Tissue Int. 80: 211-219Dhaliwal R. Cibula D. Ghosh C. Weinstock R. Moses A.

Bone quality assessment in type 2 diabetes mellitus.

Osteoporos. Int. 25: 1969-1973

The dependence of transversely isotropic elasticity of human femoral cortical bone on porosity.

J. Biomech. 37: 1281-1287Du J.Y. Flanagan C.D. Bensusan J.S. Knusel K.D. Akkus O. Rimnac C.

Raman biomarkers are associated with cyclic fatigue life of human allograft cortical bone.

J. Bone Joint Surg. (Am. Vol.). 101: e85(1-6)Erdal N. Gurgul S. Kavak S. Yildiz A. Emre M.

Deterioration of bone quality by streptozotocin (STZ)-induced type 2 diabetes mellitus in rats.

Biol. Trace Elem. Res. 140: 342-353Fernando O. Tiffany G. Xu G. Patel A.J. Grayson T.B. Thielen L.A. Peng L. Anath S.

Verapamil and beta cell function in adults with recent-onset type 1 diabetes.

Nat. Med. 24: 1108-1112Gaeta M. Mileto A. Ascenti G. Bernava G. Murabito A. Minutoli F.

Bone stress injuries of the leg in athletes.

La Radiol. Medica. 118: 1034-1044Hamann C. Rauner M. Höhna Y. Bernhardt R. Mettelsiefen J. Goettsch C. Günther K.P. Stolina M. Han C.Y. Asuncion F.J.

Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus.

J. Bone Miner. Res. 28: 627-638

Biochemical relationships between bone turnover markers and blood glucose in patients with type 2 diabetes mellitus.

Diabetes Metabol. Synd.: Clin. Res. Rev.s. 11: S369-S372Janghorbani M. Dam R.M.V. Willett W.C. Hu F.B.

Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture.

Am. J. Epidemiol. 166: 495-505Jung H. Kim Hyung Jin Choi Eu Jeong Ku Kyoung

Trabecular bone score as an indicator for skeletal deterioration in diabetes.

J. Clin. Endocrinol. Metab. 100: 475-482

Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties.

Bone. 82: 21-27Kerckhofs G. Durand M. Vangoitsenhoven R. Marin C. Van D. Carmeliet G. Luyten F.P. Geris L. Vandamme K.

Changes in bone macro- and microstructure in diabetic obese mice revealed by high resolution microfocus X-ray computed tomography.

Sci. Rep. 6 ()Khodneva Y. Shalev A. Frank S.J. Carson A.P. Safford M.M.

Calcium channel blocker use is associated with lower fasting serum glucose among adults with diabetes from the REGARDS study.

Diabetes Res. Clin. Pract. 115: 115-121

Fatigue behavior of cortical bone: a review.

Acta Mech. Sinica. 37: 516-526Liu X. Li W. Cai J. Yan Z. Shao X. Xie K. Guo X.E. Luo E. Jing D.

Spatiotemporal characterization of microdamage accumulation and its targeted remodeling mechanisms in diabetic fatigued bone.

FASEB J. 34: 2579-2594Lonsberry B.B. Dubo D.F. Thomas S.M. Docherty J.C. Maddaford T.G. Pierce G.N.

Effect of high-dose verapamil administration on the Ca2+ channel density in rat cardiac tissue.

Pharmacology. 49: 23-32Malayeri A. Zakerkish M. Ramesh F. Galehdari H. Hemmati A.A. Angali K.A.

The effect of verapamil on TXNIP gene expression, GLP1R mRNA, FBS, HbA1c, and lipid profile in T2DM patients receiving metformin and Sitagliptin.

Diabetes Therapy. 12: 2701-2713Merlo K. Aaronson J. Vaidya R. Rezaee T. Chalivendra V. Karim L.

In vitro-induced high sugar environments deteriorate human cortical bone elastic modulus and fracture toughness.

J. Orthop. Res. 38: 972-983Napoli N. Chandran M. Pierroz D.D. Abrahamsen B. Schwartz A.V. Ferrari S.L.

Mechanisms of diabetes mellitus-induced bone fragility.

Nat. Rev. Endocrinol. 13: 208-219Niu H.J. Shao X.N. Wang L. Tian H.M. Fan Y.B.

Correlation study on bone density, microstructure and acoustic parameters of cancellous bone at different stages of decalcification.

J. Med. Biomech. 26: 527-533Palacio-Mancheno P.E. Larriera A.I. Doty S.B. Cardoso L. Fritton S.P.

3D assessment of cortical bone porosity and tissue mineral density using high-resolution CT: effects of resolution and threshold method.

J. Bone Miner. Res. 29: 142-150Qian C. Zhu C. Yu W. Jiang X. Zhang F.

High-fat diet/low-dose streptozotocin-induced type 2 diabetes in rats impacts osteogenesis and Wnt signaling in bone marrow stromal cells.

PLoS One. 10 ()

Physiology and pathophysiology of bone remodeling.

Clin. Chem. 45: 1353-1358Samelson E.J. Demissie S. Cupples L.A. Zhang X. Xu H. Liu C. Boyd S.K. Mclean R.R. Broe K.E. Kiel D.P.

Diabetes and deficits in cortical bone density, microarchitecture, and bone size: rramingham HR-pQCT study.

J. Bone Miner. Res. 33: 1-9Samnegård E. Sjödén G.

Verapamil induces increased bone volume and osteopenia in female rats but has the opposite effect in male rats.

Calcif. Tissue Int. 50: 524-526

Anisotropy of bovine cortical bone tissue damage properties.

J. Biomech. 46: 2-6Wynnyckyj C. Willett T.L. Omelon S. Jian W. Wang Z. Grynpas M.

Changes in bone fatigue resistance due to collagen degradation.

J. Orthop. Res. 29: 197-203Xu G. Chen J. Gu J. Shalev A.

Preventing β-cell loss and diabetes wth calcium channel blockers.

Diabetes. 61: 848-856Yasushi T. Atsunori K. Tsutomu O. Nanami A. Takayuki A. Motoyoshi I. Yoshihumi T. Yukio S.

Effect of verapamil on cardiac protein kinase C activity in diabetic rats.

Eur. J. Pharmacol. 200: 353-356Yerramshetty J.S. Akkus O.

The associations between mineral crystallinity and the mechanical properties of human cortical bone.

Bone. 42: 476-482Zeitoun D. Caliaperoumal G. Bensidhoum M. Constans J.M. Anagnostou F. Bousson V.

Microcomputed tomography of the femur of diabetic rats: alterations of trabecular and cortical bone microarchitecture and vasculature-a feasibility study.

Eur. Radiol. Exper. 3: 1-9Zimmermann E.A. Schaible E. Bale H. Barth H.D. Tang S.Y. Reichert P. Busse B. Alliston T. Ager J.W. Ritchie R.O.

Age-related changes in the plasticity and toughness of human cortical bone at multiple length scales.

Proc. Natl. Acad. Sci. U. S. A. 108: 14416-14421Zimmermann E.A. Gludovatz B. Schaible E. Busse B. Ritchie R.O.

Fracture resistance of human cortical bone across multiple length-scales at physiological strain rates.

Biomaterials. 35: 5472-5481